Adipocytokines and obesity-linked disorders.
Authors:
Open Access
- 1 February 2012
- journal article
- review article
- Vol. 74, 19-30
Abstract
Obesity is closely associated with an increased risk for metabolic and cardiovascular diseases. Adipose tissue produces a number of secretory bioactive substances, also known as adipocytokines or adipokines, which directly affect adjacent or distant organs. Most adipocytokines are pro-inflammatory, thereby promoting the obesity-linked disorders. In contrast, there are a small number of adipocytokines that exhibit antiinflammatory properties. It is now recognized that dysregulated production or secretion of adipocytokines caused by adipocyte dysfunction leads to the development of obesity-linked complications. In this review, we focus on the functional role of several adipocytokines in metabolic and cardiovascular diseases.Keywords
This publication has 74 references indexed in Scilit:
- Adipolin/C1qdc2/CTRP12 Protein Functions as an Adipokine That Improves Glucose MetabolismJournal of Biological Chemistry, 2011
- Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent MechanismJournal of Biological Chemistry, 2011
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in ObesityScience, 2010
- Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory PhenotypeJournal of Biological Chemistry, 2010
- Caloric Restriction Stimulates Revascularization in Response to Ischemia via Adiponectin-mediated Activation of Endothelial Nitric-oxide SynthaseJournal of Biological Chemistry, 2009
- A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin ResistanceScience, 2008
- Adiponectin protects against the development of systolic dysfunction following myocardial infarctionJournal of Molecular and Cellular Cardiology, 2007
- Inflammation and metabolic disordersNature, 2006
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003